1. Home
  2. CTXR vs FAMI Comparison

CTXR vs FAMI Comparison

Compare CTXR & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.67

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$1.34

Market Cap

16.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTXR
FAMI
Founded
2007
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
16.7M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
CTXR
FAMI
Price
$0.67
$1.34
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
811.4K
21.0K
Earning Date
05-12-2026
08-04-2025
Dividend Yield
N/A
N/A
EPS Growth
43.38
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$147.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.09
52 Week High
$2.38
$2.12

Technical Indicators

Market Signals
Indicator
CTXR
FAMI
Relative Strength Index (RSI) 48.11 51.99
Support Level $0.64 $1.35
Resistance Level $0.99 $1.49
Average True Range (ATR) 0.06 0.12
MACD 0.01 0.00
Stochastic Oscillator 68.05 59.09

Price Performance

Historical Comparison
CTXR
FAMI

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: